The Motley Fool

Key Data Points

Primary metrics and data points about Rexahn Pharmaceuticals.
Current Price: $0.54
Prev Close: $0.52
Open: $0.54
Bid: $0.55
Ask: $0.60
Day's Range: $0.52 - $0.54
52wk Range: $0.50 - $0.96
Volume: 177,642
Avg Vol 325,311
Market Cap: $97M
P/E (ttm): -7.43
EPS (ttm): ($0.07)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about Rexahn Pharmaceuticals from

Business Summary

Industry, sector and description for Rexahn Pharmaceuticals.

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

RNN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Rexahn Pharmaceuticals.
CAPS Rating 3 out of 5
94 Outperform
15 Underperform
CAPS All Stars
12 Outperform
6 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Chang H. Ahn, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Rexahn Pharmaceuticals

Primary metrics and data points about Rexahn Pharmaceuticals.